In vivo gene transfer studies on the regulation and function of the vasopressin and oxytocin genes

Journal of Neuroendocrinology

Volumn 15, Issue 2, 2003, Pages 109-125

  Murphy, David ^a   Wells, S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Germline transgenic rodents; Hypothalamic neurohypophysial system; Oxytocin; Somatic gene transfer; Vasopressin

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; DNA FRAGMENT; MESSENGER RNA; NEUROPEPTIDE; OXYTOCIN; SPACER DNA; VASOPRESSIN;

ANIMAL CELL; BRAIN NERVE CELL; CATTLE; CELL FUNCTION; CELL SPECIFICITY; CONTROLLED STUDY; DIABETES INSIPIDUS; EXPRESSION VECTOR; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENE TRANSFER; GERM LINE; GIANT NERVE CELL; HYPOTHALAMUS; IN VIVO STUDY; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; REPORTER GENE; REVIEW; STEREOTAXIS; STRUCTURAL GENE; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; TRANSGENE; TRANSGENIC ANIMAL; VIRUS REPLICATION; ZYGOTE;

ANIMALS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OXYTOCIN; VASOPRESSINS;

EID: 0037322298     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2003.00964.x     Document Type: Review

References (138)

1. Brenner S. Loose ends. Curr Biol 1994; 4: 864.
2. Schmitz E, Mohr E, Richter D. Rat vasopressin and oxytocin genes are linked by a long interspersed repeated DNA element (LINE): sequence and transcriptional analysis of LINE. DNA Cell Biol 1991; 10: 81-91.
3. Ratty AK, Jeong S-W, Nagle JW, Chin H, Gainer H, Murphy D, Venkatesh B. A systematic survey of the intergenic region between the murine oxytocin- and vasopressin-encoding genes. Gene 1996; 174: 71-78.
4. Xi D, Kusano K, Gainer H. Quantitative analysis of oxytocin and vasopressin messenger ribonucleic acids in single magnocellular neurons isolated from supraoptic nucleus of rat hypothalamus. Endocrinology 1999; 140: 4677-4682.
5. Brownstein M, Russel J, Gainer H. Synthesis, transport and release of posterior pituitary hormones. Science 1980; 207: 373-378.
6. Glasgow E, Kusano K, Chin H, Mezey E, Young WS, 3rd Gainer H. Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology 1999; 140: 5391-5401.
7. de Bree FM, Knight D, Murphy D. Sorting of the vasopressin prohormone into the regulated secretory pathway. FEBS Lett 2000; 475: 175-180.
8. Bargman W. Neurosecretion. Int Rev Cytol 1966; 19: 183-201.
9. Reeves WB, Andreoli TE. The posterior pituitary and water metabolism. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia: WB Saunders, 1992: 311-356.
10. Bourque CW, Oliet SH, Richard D. Osmoreceptors, osmoreception and osmoregulation. Front Neuroendocrinol 1994; 15: 231-274.
11. Young WS, Shepard E, De Vries AC, Zimmer A, LaMarca ME, Ginns EI, Amico J, Nelson RJ, Hennighausen L, Wagner KU. Targeted reduction of oxytocin expression provides insights into its physiological roles. Adv Exp Med Biol 1998; 449: 231-240.
12. Russell JA, Leng G. Sex, parturition and motherhood without oxytocin. J Endocrinol 1998; 157: 343-359.
13. Verbalis JG, Mangione MP, Stricker EM. Oxytocin produces natriuresis in rats at physiological plasma concentrations. Endocrinology 1991; 128: 1317-1322.
14. Huang W, Lee SL, Arnason SS, Sjoquist M. Dehydration natriuresis in male rats is mediated by oxytocin. Am J Physiol 1996; 270: R427-R433.
15. Vandesande F, Dierickx K, De Mey J. The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis. Cell Tissue Res 1977; 180: 443-452.
16. Gillies GE, Linton EA, Lowry PJ. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982; 299: 355-357.
17. Moore RY. Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. Fed Proc 1983; 42: 2783-2789.
18. Kalsbeek A, Van Der Vliet J, Buijs RM. Decrease of endogenous vasopressin release necessary for expression of the circadian rise in plasma corticosterone: a reverse microdialysis study. J Neuroendocrinol 1996; 8: 299-307.
19. Kalsbeek A, van Heerikhuiz JJ, Wortel J, Buijs RM. A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J Neurosci 1996; 16: 5555-5565.
20. Van Tol HH, Bolwerk EL, Liu B, Burbach JP. Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy, and lactation. Endocrinology 1988; 122: 945-951.
21. Murphy D, Carter DA. Vasopressin gene expression in the rodent hypothalamus: transcriptional and post-transcriptional responses to physiological stimulation. Mol Endocrinol 1990; 4: 1051-1059.
22. Herman JP, Schafer MK, Watson SJ, Sherman TG. In situ hybridization analysis of arginine vasopressin gene transcription using intron-specific probes. Mol Endocrinol 1991; 5: 1447-1456.
23. Burbach JPH, de Hoop MJ, Schmale H, Richter D, de Kloet ER, Ten Haaf JA, de Wied D. Differential responses to osmotic stress of vasopressin-neurophysin mRNA in hypothalamic nuclei. Neuroendocrinology 1984; 39: 582-584.
24. Zingg HH, Lefebvre D, Almazan G. Regulation of vasopressin gene expression in hypothalamic neurons. J Biol Chem 1986; 261: 12956-12959.
25. Lightman SL, Young WS. Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin releasing factor mRNA stimulation in the rat. J Physiol 1987; 394: 23-39.
26. Sherman TG, Day R, Civelli O, Douglas J, Herbert E, Akil H, Watson SJ. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge. J Neurosci 1988; 8: 3785-3796.
27. Van Tol HHM, Voorhuis TAM, Burbach JPH. Oxytocin gene expression in discrete hypothalamic magnocellular groups is stimulated by prolonged salt loading. Endocrinology 1987; 120: 71-76.
28. Ma XM, Levy A, Lightman SL. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA. Endocrinology 1997; 138: 4351-4357.
29. Carter DA, Murphy D. Nuclear mechanisms mediate rhythmic changes in vasopressin mRNA expression in the rat suprachiasmatic nucleus. Mol Brain Res 1991; 12: 315-321.
30. Murphy D, Carter DA, eds. Transgenesis Techniques: Principles and Protocols. Methods in Molecular Biology, vol. 18. New Jersey: Humana Press, 1993.
31. Si-Hoe S-L, Wells S, Murphy D. Production of transgenic rodents by the microinjection of cloned DNA into fertilized one-cell eggs. Mol Biotechnol 2001; 17: 151-182.
32. Bjorklund S, Kim Y-J. Mediator of transcription regulation. Trend Biochem Sci 1996; 21: 335-337.
33. Verrijzer CP, Tijan R. TAFs mediate transcriptional activation and promoter selectivity. Trend Biochem Sci 1996; 21: 338-342.
34. Banerji J, Olson L, Schaffner W. A lymphocytes-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 1983; 33: 729-740.
35. Queen C, Baltimore D. Immunoglobulin gene transcription is activated by downstream elements. Cell 1983; 33: 741-748.
36. Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 1983; 33: 717-728.
37. Ornitz DM, Palmiter RD, Hammer RE, Brinster RL, Swift GH, MacDonald RJ. Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice. Nature 1985; 313: 600-602.
38. Selden RF, Skoskiewicz MJ, Howie KB, Russell PS, Goodman HM. Regulation of human insulin gene expression in transgenic mice. Nature 1986; 321: 525-528.
39. Murphy D, Bishop A, Rindi G, Murphy MN, Stamp G, Hanson J, Polak J, Hogan BLM. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary: a possible model for human multiple endocrine neoplasia. Am J Pathol 1997; 129: 552-566.
40. Ang H-L, Carter DA, Murphy D. Neuron-specific and physiological regulation of bovine vasopressin transgenes in mice. EMBO J 1993; 12: 2397-2409.
41. Rubinstein M, Liu B, Goodman RH, Low MJ. Targeted expression of somatostatin in vsaopressinergic magnocellular hypothalamic neurons of transgenic mice. Mol Cell Neurosci 1992; 3: 152-161.
42. Swanson LW, Simmons DM, Arriza J, Hammer R, Brinster R, Rosenfeld MG, Evans RM. Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. Nature 1985; 317: 363-366.
43. Gainer H, Young WS. Transgenic models for studies of oxytocin and vasopressin. In: Castro M, ed. Transgenic Models in Endocrinology. London: Kluwer, 2001: 25-46.
44. Wray S, Gainer H. Models for the study of cell-specific neuropeptide gene expression. Prog Brain Res 1992; 92: 59-76.
45. Zeng Q, Foo N-C, Funkhouser JM, Carter DA, Murphy D. Expression of a rat vasopressin transgene in rat testes. J Reprod Fert 1994; 102: 471-481.
46. Gainer H, Fields RL, House SB. Vasopressin gene experimental models and strategies. Exp Neurol 2001; 171: 190-199.
47. Young WS, Reynolds K, Shepard EA, Gainer H, Castel M. Cell specific expression of the rat oxytocin gene in transgenic mice. J Neuroendocrinol 1990; 2: 917-925.
48. Grant FD, Reventos J, Gordon JW, Kawabata S, Miller M, Majzoub JA. Expression of rat arginine vasopressin gene in transgenic mice. Mol Endocrinol 1993; 7: 659-667.
49. Zeng Q, Carter DA, Murphy D. Cell specific expression of a vasopressin transgene in rats. J Neuroendocrinol 1994; 6: 469-477.
50. Si-Hoe S-L, de Bree FM, Nijenhuis M, Davies JE, Howell LMC, Tinley H, Waller SJ, Zeng Q, Zalm R, Sonnemans M, Van Leeuwen FW, Burbach JPH, Murphy D. Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophysial diabetes insipidus mutant vasopressin transgene. FASEB J 2000; 14: 1680-1684.
51. Jeong SW, Castel M, Zhang BJ, Fields RL, Paras P, Arnheiter H, Chin H, Gainer H. Cell-specific expression and subcellular localization of neurophysin-CAT-fusion proteins expressed from oxytocin and vasopressin gene promoter-driven constructs in transgenic mice. Exp Neurol 2001; 171: 255-271.
52. Gainer H, Wray S. Oxytocin and vasopressin. From genes to peptides. Ann NY Acad Sci 1992; 652: 14-28.
53. Ho M-Y, Carter DA, Ang H-L, Murphy D. Bovine oxytocin transgenes in mice: hypothalamic expresion, physiological regulation and interactions with the vasopressin gene. J Biol Chem 1995; 270: 27199-27205.
54. Belenky M, Castel M, Young WS III, Gainer H, Cohen S. Ultrastructural immunolocalization of rat oxytocin-neurophysin in transgenic mice expressing the rat oxytocin gene. Brain Res 1992; 583: 279-286.
55. Gainer H, Wray S. The cellular and molecular biology of oxytocin and vasopressin. In: Knobil E, Neill JD, eds. Physiology of Reproduction, 2nd edn. New York: Raven Press, 1994: 1099-1129.
56. Ang H-L, Ungerfroren H, de Bree F, Foo N-C, Carter DA, Burbach JP, Ivell R, Murphy D. Testicular oxytocin gene expression in seminiferous tubules of cattle and transgenic mice. Endocrinology 1991; 128: 2110-2117.
57. Waller S, Fairhall KM, Xu J, Robinson ICAF, Murphy D. Neurohypophysial and fluid homeostasis in transgenic rats expressing a tagged rat vasopressin prepropeptide in hypothalamic neurons. Endocrinology 1996; 137: 5068-5077.
58. Carter DA, Murphy D. Cyclic nucleotide dynamics in the rat hypothalamus during osmotic stimulation: in vivo and in vitro studies. Brain Res 1989; 487: 350-356.
59. Young WS, Shepard EA, Burch RM. Plasma hyperosmolality increases G protein and 3′,5′-cyclic adenosine monophosphate synthesis in the paraventricular and supraoptic nuclei. Mol Endocrinol 1987; 1: 884-888.
60. Emanuel RL, Girard DM, Thull DL, Majzoub JA. Regulated expression of vasopressin gene by cAMP and phorbol esters in primary rat fetal hypothalamic cultures. Mol Cell Endocrinol 1992; 2: 29-36.
61. Sladek CD, Gallagher MJ. The stimulation of vasopressin gene expression in cultured hypothalamic neurons by cyclic adenosine 3′,5′-monophosphate is reversible. Endocrinology 1993; 133: 1320-1330.
62. Sladek CD, Fisher KY, Sidorowicz HE, Mathiasen JR. cAMP regulation of vasopressin mRNA content in hypothalamo-neurohypophysial explants. Am J Physiol 1996; 271: R554-R560.
63. Iwasaki Y, Oiso Y, Saiti H, Majzoub JA. Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 1997; 138: 5266-5274.
64. Emanuel RL, Iwasaki Y, Arbiser ZK, Velez EM, Emerson CH, Majzoub JA. Vasopressin messenger ribonucleic acid regulation via the protein kinase A pathway. Endocrinology 1998; 139: 2831-2837.
65. Pardy K, Adan RAH, Carter DA, Seah V, Burbach JPH, Murphy D. The identification of a cis-acting element involved in the cyclic-3′,5′-adenosine monophosphate regulation of bovine vasopressin gene expression. J Biolchem 1992; 267: 21746-21752.
66. Fitzsimmons MD, Roberts MM, Sherman TG, Robinson AG. Models of neurohypophysial homeostasis. Am J Physiol 1992; 262: R1121-R1130.
67. Fitzsimmons MD, Roberts MM, Robinson AG. Control of posterior pituitary vasopressin content: implications for the control of the vasopressin gene. Endocrinology 1994; 134: 1874-1878.
68. Adan RA, Cox JJ, Beischlag TV, Burbach JP. A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol Endocrinol 1993; 7: 47-57.
69. Carrazana EJ, Pasieka KB, Majzoub JA. The vasopressin mRNA poly (A) tract is unusually long and increases during stimulation of vasopressin gene expression in vivo. Mol Cell Biol 1988; 8: 2267-2274.
70. Chaturvedi CM, Zheng Z, Shimada K, Cornett LE, Koike TI. Changes in poly (A) tail length of arginine vasotocin messenger ribonucleic acid in the hypothalamus of water deprived chickens. Gen Comp Endocrinol 1996; 103: 316-322.
71. Si-Hoe S-L, Carter DA, Murphy D. Physiological regulation of vasopressin mRNA abundance and poly (A) tail length: tissue and species differences revealed by comparative analysis in transgenic rodents. Physiol Genomics 2001; 5: 1-9.
72. Murphy D, Levy A, Lightman S, Carter DA. Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt-loading. Proc Natl Acad Sci USA 1989; 86: 9002-9005.
73. Levy A, Lightman SL, Carter DA, Murphy D. The origin and regulation of posterior pituitary vasopressin ribonucleic acid in osmotically stimulated rats. J Neuroendocrinol 1990; 3: 329-334.
74. McCabe JT, Lehman E, Chastrette N, Hanze J, Lang RE, Ganten D, Pfaff DW. Detection of vasopressin mRNA in the neurointermediate lobe of the rat pituitary. Mol Brain Res 1990; 8: 325-329.
75. Lehman E, Hanze J, Pauschinger M, Ganten D, Lang RE. Vasopressin mRNA in the neurolobe of the pituitary. Neurosci Lett 1990; 111: 170-175.
76. Mohr E, Zhou A, Thorn NA, Richter D. Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe. FEBS Lett 1990; 263: 332-336.
77. Mohr E, Fehr S, Richter D. Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-hypophyseal tract of rats. EMBO J 1991; 10: 2419-2424.
78. Murphy D, Funkhouser J, Ang H-L, Foo N-C, Carter DA. Extrahypothalamic expression of the vasopressin and oxytocin genes. Ann NY Acad Sci 1993; 689: 91-106.
79. Trembleau A, Morales M, Bloom FE. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence. J Neurosci 1994; 14: 39-53.
80. Mohr E, Morris JF, Richter D. Differential subcellular mRNA targeting: deletion of a single nucleotide prevents the transport to axons but not dendrites of rat hypothalamic magnocellular neurons. Proc Natl Acad Sci USA 1995; 92: 4377-4381.
81. Pu L-P, van Leeuwen FW, Tracer H, Sonnemans MAF, Loh YP. Localisation of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation. Proc Natl Acad Sci USA 1995; 92: 10653-10657.
82. Trembleau A, Morales M, Bloom FE. Differential compartmentalisation of vasopressin messenger RNA and neuropeptide within the rat hypothalamo-neurohypophysial axonal tract: light and electron microscopic evidence. Neuroscience 1996; 70: 113-125.
83. Jirikowski GF, Sanna PP, Maciejewski-Lenoir D, Bloom FE. Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA. Science 1992; 255: 996-998.
84. Murphy D, Ang H-L, Zeng Q, Ho M-Y, Funkhouser J, Carter DA. Neuropeptide gene expression in transgenic animals. Prog Brain Res 1992; 92: 77-96.
85. Maciejewski-Lenoir D, Jirikowski GF, Sanna PP, Bloom FE. Reduction of exogenous vasopressin RNA poly (A) tail length increases its effectivenes in transiently correcting diabetes insipidus in the rat. Proc Natl Acad Sci USA 1992; 90: 1435-1439.
86. Boersma CJC, Sonnemans MAF, van Leewen FW. Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe. Brain Res 1993; 611: 117-129.
87. Janaky T, Szabo P, Kele Z, Balaspiri L, Varga C, Galfi M, Vecsernyes M, Gaspar L, Juhasz A, Laszlo FA. Identification of oxytocin and vasopressin from neurohypophysial cell culture. Rapid Commun Mass Spectrom 1998; 12: 1765-1768.
88. Fehn M, Lohmann F, Ludecke DK, Rudorff KH, Saeger W. Ganglioglioma of the neurohypophysis with secretion of vasopressin. Exp Clin Endocrinol Diabetes 1998; 106: 425-430.
89. Murphy D, Xu J, Waller S. Transgenic studies on the osmotic regulation of vasopressin gene expression. Exp Physiol 2000; 85S: 211S-222S.
90. Ivell R, Burbach JPH. The molecular biology of vasopressin and oxytocin genes. J Neuroendocrinol 1991; 3: 583-586.
91. Burke ZD, Morgan H, Murphy D, Carter DA. RNAs encoded by a 3.5 kb bovine vasopressin gene construct are targeted to the neurohypophysis of transgenic mice. Mol Brain Res 1996; 42: 287-292.
92. Olsen SR, Uhler MD. Inhibition of protein kinase A by overexpression of the cloned human protein kinase inhibitor. Mol Endocrinol 1991; 5: 1246-1256.
93. Pearson JD, DeWald DB, Mathews WR, Mozier NM, Zurcher-Neely HA, Heinrikson RL, Morris MA, McCubbin WD, McDonald JR, Fraser ED, Vogel HJ, Kay CM, Walsh MP. Amino acid sequence and characterisation of a protein inhibitor of protein kinase C. J Biol Chem 1990; 265: 4583-4591.
94. Waller SJ, Murphy D. Expression of rat vasopressin transgenes in rats. In: Saito T, Kurokawa K, Yoshida S, eds. The First Joint World Congress of Neurohypophysis and Vasopressin. Excerpta Medica International Congress, Series 1098. Amsterdam: Elsevier Science, 1995: 89-98.
95. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999; 96: 307-310.
96. Young WS, Iacangelo A, Luo XZ, King C, Duncan K, Ginns EI. Transgenic expression of green fluorescent protein in mouse oxytocin neurones. J Neuroendocrinol 1999; 11: 935-939.
97. Pelletier J, Sonnenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988; 334: 320-325.
98. Zhang BJ, Kusano K, Zerfas P, Iacangelo A, Young WS, Gainer H. Targeting of green fluorescent protein to secretory granules in oxytocin magnocellular neurons and its secretion from neurohypophysial nerve terminals in transgenic mice. Endocrinology 2002; 143: 1036-1046.
99. Baylis PH, Robertson GL. Vasopressin function in familial cranial diabetes insipidus. Postgrad Med J 1981; 57: 36-40.
100. Hansen LK, Rittig R, Robertson GL. Genetic basis of familial neurohypophysial diabetes insipidus. TEM 1997; 8: 363-372.
101. Ito M, Jameson JL, Ito M. Molecular basis of autosomal dominant neurohypophysial diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 1997; 99: 1897-1905.
102. Ito MYuRN, Jameson JL. Mutant vasopressin precursors that cause autosomal dominant neurohypophysial diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 1999; 274: 9029-9037.
103. Bahnsen U, Oosting P, Swaab DF, Nahke P, Richter D, Schmale H. A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophysial diabetes insipidus. EMBO J 1992; 11: 19-23.
104. Grant FD. Genetic models of vasopressin deficiency. Exp Physiol 2000; 85S: 203S-209S.
105. Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H, Oiso Y. Two novel mutations in the coding region for neurophysin-II with familial central diabetes insipidus. J Clin Endocrinol Metab 1995; 80: 1352-1356.
106. Davies J, Murphy D. Autophagy in hypothalamic neurons of rats expressing a familial neurohypophysial diabetes insipidus transgene. J Neuroendocrinol 2002; 14: 629-637.
107. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 1996;93: 11699-11704.
108. Young WS, Shepard E, Amico J, Hennighausen K-U, Wagner ME, La Marca ME, McKinney C, Ginns EI. Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol 1996; 8: 847-854.
109. Amoroso EC, Porter DG. Anterior pituitary function in pregnancy. In: Harris GW, Donovan BT, eds. The Pituitary Gland, vol. 2. London: Butterworth, 1966: 364-411.
110. Ho M-Y, Murphy D. A bovine oxytocin transgene in mice: expression in the female reproductive organs and regulation during pregnancy, parturition and lactation. Mol Cell Endocrinol 1997; 136: 15-21.
111. Ivell R, Rust W, Einsanier A, Hartung S, Fields M, Fuchs A-R. Oxytocin and oxytocin receptor gene expression in the reproductive tract of the pregnant cow: rescue of luteal oxytocin production at term. Biol Reprod 1995; 53: 553-560.
112. Brenner S, Elgar G, Sandford R, Macrae A, Venkatesh B, Aparicio S. Characterisation of the pufferfish (Fugu) genome as a compact model vertebrate genome. Nature 1993; 366: 265-268.
113. Goossens N, Diericks K, Vandesande F. Immunocytochemical localization of vasotocin and isotocin in the preopticohypophysial neurosecretory system of teleosts. Gen Comp Endocrinol 1977; 32: 371-375.
114. Hyodo S, Urano A. Changes in expression of provastocin and proisotocin genes during adaptation to hyper- and hypo-osmotic environments in rainbow trout. J Comp Physiol B 1991; 161: 549-556.
115. Venkatesh B, Si-Ho S-L, Murphy D, Brenner S. Transgenic rats reveal remarkable functional conservation of regulatory controls between the fish isotocin and rat oxytocin genes. Proc Natl Acad Sci USA 1997; 94: 12462-12466.
116. Murphy D, Si-Hoe S-L, Brenner S, Venkatesh B. Something fishy in the rat brain: molecular genetics of the hypothalamo-neurohypophysial system. Bioessays 1998; 20: 741-749.
117. Nelson RJ. The use of genetic 'knockout' mice in behavioral endocrinology research. Horm Behav, 1997; 31: 188-196.
118. Routtenberg A. Knockout mouse fault lines. Nature 1995; 374: 314.
119. Thomas JH. Thinking about genetic redundancy. Trends Genet 1993; 9: 395.
120. Hochgeschwender U, Brennan MB. Mouse knockouts rule OK. Nature 1995; 375: 543.
121. Nowak MA, Boerlijst MC, Cooke J, Smith JM. Evolution of genetic redundancy. Nature 1997; 388: 167-171.
122. Butcher JW, De Felipe C, Smith AJ, Hunt SP, Paton JF. Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo. J Auton Nerv Syst 1998; 69: 89-95.
123. Geddes BJ, Harding TC, Lightman SL, Uney JB. Assessing viral gene therapy in neuroendocrine models. Front Neuroendocrinol 1999; 20: 296-316.
124. Geddes BJ, Harding TC, Hughes DS, Byrnes AP, Lightman SL, Conde G, Uney JB. Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin. Endocrinology 1996; 137: 5166-5169.
125. Geddes BJ, Harding TC, Lightman SL, Uney J. Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Med 1997; 3: 1402-1404.
126. Schobitz B, Pezeshki G, Probst JC, Reul JM, Skutella T, Stohr T, Holsboer F, Spanagel R. Centrally administered oligonucleotides in rats: occurance of non-specific effects. Eur J Pharmacol 1997; 331: 97-107.
127. Branch AD. A good antisense molecule is hard to find. Trends Biochem Sci 1998; 23: 45-50.
128. Flanagan LM, McCarthy MM, Brooks PJ, Ptaff DW, McEwan BS. Arginine vasopressin levels after daily infusions of antisense oligonucleotides into the supraoptic nucleus. Ann NY Acad Sci 1993; 689: 520-521.
129. Skutella T, Probst JC, Engelmann CT, Wotjak CT, Landgraf R, Jirikowski GF. Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats. J Neuroendocrinol 1994; 6: 121-125.
130. Meeker R, LeGrand G, Ramirez J, Smith T, Shih YH, Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioural effects. J Neuroendocrinol 1995; 7: 419-428.
131. Neumann I, Porter DW, Landgraf R, Pittman QJ. Rapid effect on suckling of an antisense oligonucleotide administered into the rat supraoptic nucleus. Am J Physiol 1994; 267: R852-R858.
132. Jirikowski GF, Celeda D, Jantz M, Prufer K, Lee JS. Sense- and antisense-targeting of oxytocinergic systems in rat hypothalamus. Adv Exp Med Biol 1995; 395: 59-65.
133. Skutella T, Probst JC, Caldwell JD, Pederson CA, Jirikowski GF. Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactaion in rats. Exp Clin Endocrinol Diabetes 1995; 103: 191-195.
134. Neumann I, Pittman QJ, Landgraf R. Release of oxytocin within the supraoptic nucleus. Mechanisms, physiological significnce and anti-sense targeting. Adv Exp Med Biol 1995; 395: 173-183.
135. Neumann I, Kremarik P, Pittman QJ. Acute, sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses. Neuroscience 1995; 69: 997-1003.
136. Sanna PP, Jirikowski GF, Maciejewski-Lenoir D, Bloom FE. Expression of exogenous vasopressin mRNA by magnocellular neurons of the supraoptic and paraventricular nuclei of Brattleboro rats. Ann NY Acad Sci 1992; 652: 462-465.
137. Young RA. Biomedical discovery with DNA arrays. Cell 2000; 102: 9-15.
138. Murphy D. Gene expression studies using microarrays, principles, problems and prospects. Adv Physiol Educ 2000; 26: 256-270.